Savara Inc SEC filings SVRA
Savara Inc has 1,000 filings in SEC EDGAR's recent list, going back to Jul 22, 2009. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jun 8, 2026 (officer or director change, bylaw or fiscal year change, shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Sep 25, 2026 | Sep 24, 2026 |
| S-8 | Employee stock plan registration | Aug 11, 2026 | — |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 24, 2026 | Jul 15, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 22, 2026 |
| 144 | Notice of proposed sale | Jun 22, 2026 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 8, 2026 | Jun 4, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 4, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 18, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 13, 2026 | Mar 10, 2026 |
| 10-K | Annual report | Mar 13, 2026 | Dec 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Feb 17, 2026 | Feb 16, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| 8-K |
Current report
Material agreement, New debt
|
Jan 27, 2026 | Jan 26, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 21, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Dec 19, 2025 | Dec 19, 2025 |
| 144 | Notice of proposed sale | Dec 18, 2025 | — |
| 4 | Insider transaction | Dec 16, 2025 | Dec 14, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 14, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 14, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 14, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 14, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 4, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Dec 4, 2025 | Dec 2, 2025 |
| 4 | Insider transaction | Nov 17, 2025 | Nov 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 5, 2025 | — |
| 424B5 | Prospectus supplement | Oct 30, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Oct 30, 2025 | Oct 29, 2025 |
| 424B5 | Prospectus supplement | Oct 29, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Oct 29, 2025 | Oct 29, 2025 |
| 4 | Insider transaction | Oct 22, 2025 | Oct 20, 2025 |
| 3 | Initial insider ownership | Oct 22, 2025 | Oct 17, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 17, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 2, 2025 | Sep 2, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 8, 2025 | — |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 8-K |
Current report
Other events
|
May 27, 2025 | May 27, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 5, 2025 |
| 10-K/A | Amended annual report | Apr 25, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Apr 1, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Agreement ended
|
Mar 31, 2025 | Mar 31, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 27, 2025 | — |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Regulation FD disclosure
|
Mar 26, 2025 | Mar 26, 2025 |
| 3 | Initial insider ownership | Mar 21, 2025 | Mar 13, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 11, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 10, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jan 23, 2025 | Jan 23, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 144 | Notice of proposed sale | Dec 16, 2024 | — |
| 144 | Notice of proposed sale | Dec 16, 2024 | — |
| 144 | Notice of proposed sale | Dec 16, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 27, 2024 | — |
| 4 | Insider transaction | Nov 20, 2024 | Nov 19, 2024 |
| 4 | Insider transaction | Nov 18, 2024 | Nov 18, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 4 | Insider transaction | Nov 12, 2024 | Nov 10, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 6, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 24, 2024 | — |
| 4 | Insider transaction | Oct 22, 2024 | Oct 21, 2024 |
| S-8 | Employee stock plan registration | Oct 1, 2024 | — |
| 4 | Insider transaction | Sep 27, 2024 | Sep 25, 2024 |
| 3 | Initial insider ownership | Sep 27, 2024 | Sep 24, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 14, 2024 | — |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| S-8 | Employee stock plan registration | Jul 26, 2024 | — |
| 4 | Insider transaction | Jul 22, 2024 | Jul 21, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 8, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jun 28, 2024 | Jun 27, 2024 |
| 424B5 | Prospectus supplement | Jun 28, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 26, 2024 | Jun 26, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Jun 10, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 7, 2024 | Jun 6, 2024 |
| EFFECT | Filing | May 21, 2024 | — |
| CORRESP | Letter to the SEC | May 20, 2024 | — |
| UPLOAD | Letter from the SEC | May 14, 2024 | — |
| S-3 | Shelf registration | May 9, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Apr 23, 2024 | Apr 21, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Apr 12, 2024 | — |
| PRE 14A | Preliminary proxy statement | Apr 12, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Apr 12, 2024 | Apr 10, 2024 |
| 3 | Initial insider ownership | Mar 29, 2024 | Mar 21, 2024 |
| S-8 | Employee stock plan registration | Mar 7, 2024 | — |
| 10-K | Annual report | Mar 7, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement
|
Feb 16, 2024 | Feb 13, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 7, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 1, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 31, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jan 25, 2024 | Jan 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2024 | Jan 5, 2024 |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| 144 | Notice of proposed sale | Dec 28, 2023 | — |
| 144 | Notice of proposed sale | Dec 28, 2023 | — |
| 144 | Notice of proposed sale | Dec 28, 2023 | — |
| 4 | Insider transaction | Dec 18, 2023 | Dec 14, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 14, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 14, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 14, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 14, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 14, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 14, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 15, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 14, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 14, 2023 |
| 4 | Insider transaction | Dec 12, 2023 | Dec 11, 2023 |
| 4 | Insider transaction | Dec 12, 2023 | Dec 11, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Jul 26, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Jul 25, 2023 | — |
| 4 | Insider transaction | Jul 19, 2023 | Jul 17, 2023 |
| 4 | Insider transaction | Jul 19, 2023 | Jul 17, 2023 |
| 4 | Insider transaction | Jul 19, 2023 | Jul 17, 2023 |
| 4 | Insider transaction | Jul 19, 2023 | Jul 17, 2023 |
| 4 | Insider transaction | Jul 19, 2023 | Jul 17, 2023 |
| 4 | Insider transaction | Jul 19, 2023 | Jul 17, 2023 |
| 4 | Insider transaction | Jul 19, 2023 | Jul 17, 2023 |
| 4 | Insider transaction | Jul 19, 2023 | Jul 17, 2023 |
| 4 | Insider transaction | Jul 19, 2023 | Jul 17, 2023 |
| 4 | Insider transaction | Jul 19, 2023 | Jul 17, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Jul 19, 2023 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 13, 2023 | Jul 12, 2023 |
| 424B5 | Prospectus supplement | Jul 13, 2023 | — |
| 4 | Insider transaction | Jun 27, 2023 | Jun 26, 2023 |
| S-8 | Employee stock plan registration | Jun 16, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 8, 2023 | Jun 8, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 24, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 30, 2023 | Mar 28, 2023 |
| S-8 | Employee stock plan registration | Mar 30, 2023 | — |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Material agreement
|
Mar 2, 2023 | Feb 28, 2023 |
| 4 | Insider transaction | Feb 28, 2023 | Feb 24, 2023 |
| 3 | Initial insider ownership | Feb 22, 2023 | Feb 13, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Feb 14, 2023 | Feb 13, 2023 |
| S-8 | Employee stock plan registration | Jan 20, 2023 | — |
| 4 | Insider transaction | Jan 3, 2023 | Dec 29, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SVRA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Austin, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1160308
- Former names
- Mast Therapeutics, Inc. (until Apr 25, 2017); ADVENTRX PHARMACEUTICALS INC (until Mar 1, 2013); BIOKEYS PHARMACEUTICALS INC (until May 15, 2003)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.